<DOC>
	<DOCNO>NCT01055106</DOCNO>
	<brief_summary>The objective study evaluate efficacy safety GW05 administer 3 regimen versus metronidazole 0.75 % treatment bacterial vaginosis .</brief_summary>
	<brief_title>Dose Ranging Study Metronidazole Vaginal Gel Treatment Bacterial Vaginosis</brief_title>
	<detailed_description>This multicenter , randomize , investigator-blinded , phase 2 , dose range study GW05 vaginal gel administer 3 regimen compare metronidazole 0.75 % ( QD x 5 day ) treatment bacterial vaginosis . Subjects evaluate three timepoints ( 1 screening/baseline visit , post-treatment phone call 1 test-of-cure visit ) . The total study duration may 30 day subject . Study medication apply intravaginally daily bedtime accord assign dose schedule use supplied 5-gram vaginal applicator . Investigator blind ensure utilizing independent drug dispense coordinator site . Bacterial vaginosis ( BV ) infection vagina ( birth canal ) result overgrowth bacteria often normally find vagina . This type vaginal infection typically cause irritation . The common complaint patient suffer BV fishy-smelling vaginal discharge . The amount vaginal discharge may may increase normal discharge . The bad odor may get bad sexual intercourse menstrual period . BV also strongly associate problem pregnancy , premature ( early ) birth , increase risk sexually transmit disease . Therefore , important treat infection .</detailed_description>
	<mesh_term>Vaginal Diseases</mesh_term>
	<mesh_term>Vaginosis , Bacterial</mesh_term>
	<mesh_term>Metronidazole</mesh_term>
	<criteria>Females least 18 year age In good general health Confirmed current diagnosis bacterial vaginosis ( determine study screen ) Negative pregnancy test ( woman able become pregnant ) Must abstain sexual intercourse throughout first 7 day thes study Must abstain alcohol ingestion treatment period one day afterward Must use intravaginal product duration study Pregnant , lactating , plan become pregnant study period Menstruating time diagnosis anticipate onset menses treatment phase study Had medical event within 90 day visit ( e.g. , stroke , heart attack , etc . ) Received specific treatments/medications /therapy within designated time period prior study enrollment</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2011</verification_date>
	<keyword>bacterial vaginosis</keyword>
	<keyword>vaginal infection</keyword>
	<keyword>vaginal discharge</keyword>
	<keyword>vaginal disease</keyword>
</DOC>